Continuation and long-term maintenance treatment with Hypericum extract WS® 5570 after recovery from an acute episode of moderate depression — A double-blind, randomized, placebo controlled long-term trial
- 30 November 2008
- journal article
- research article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 18 (11), 803-813
- https://doi.org/10.1016/j.euroneuro.2008.06.006
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Efficacy and Tolerability of Hypericum Extract STW3 in Long-term Treatment with a Once-daily Dosage in Comparison with SertralinePharmacopsychiatry, 2005
- Continuation and long‐term maintenance treatment with Hypericum extract WS® 5570 after successful acute treatment of mild to moderate depression – rationale and study designInternational Journal of Methods in Psychiatric Research, 2004
- Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic reviewThe Lancet, 2003
- Treatment of Recurrent DepressionCNS Drugs, 2003
- Rationale and options for the long-term treatment of depressionHuman Psychopharmacology: Clinical and Experimental, 2002
- Hypericum perforatum - a Review of Clinical StudiesPharmacopsychiatry, 2001
- Adverse effects profile of the herbal antidepressant St. John's wort ( Hypericum perforatum L.)European Journal of Clinical Pharmacology, 1998
- Interim analyses for monitoring clinical trials that do not materially affect the type I error rateStatistics in Medicine, 1992
- Internal consistencies of the original and revised beck depression inventoryJournal of Clinical Psychology, 1984
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967